MP71-07 METFORMIN USE IN DIABETIC MEDICARE BENEFICIARIES IS ASSOCIATED WITH IMPROVED SURVIVAL FOLLOWING RADICAL CYSTECTOMY
Brian Winters(University of Washington), George R. Schade(University of Washington), Sarah K. Holt(University of Washington), John L. Gore(University of Washington), Jonathan L. Wright(Seattle University), Evan Y. Yu(University of Washington), Wayne Brisbane(University of California, Los Angeles), Jorge Ramos(Seagen (United States))
Cited by 0
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k